Archive for November 2016

Modi’s monetary magic or fatal flaw?

Abhiraj Patel Narendra Modi’s recent decision to abolish 500 and 1,000 rupee notes essentially wiped out 86% of the country’s cash and came as a shock to the Indian economy. This process known as demonetisation aimed to crack down on “black money” – hordes of corrupt cash upon which no tax has been paid. 90%…

Read More

America’s Loss, but China’s Gain

Matthew Evans On the morning of November 9th, when the world was waking up to a Donald Trump presidency, few things about the future seemed certain. However, one thing that could be easily predicted was that the Trans-Pacific Partnership (TPP), a free trade deal between 12 Pacific Rim countries, was dead. Trump had repeatedly promised…

Read More

Where do You Want to go on Holiday?

The Brexit effect on the UK tourism and airline industry Hugh Schofield After the vote to leave the EU on the 23rd of June, the pound crashed from a high of $1.50 to about $1.26.  The pound to euro also devalued from just over €1.30 to €1.16. This decrease in the value of the pound…

Read More

Black Friday brings little cheer for retailers

Fram Hansotia ‘Black Friday’, the day after Thanksgiving, traditionally referred to as the first day of the year when retailers in the US turned profitable, or shifted “into the black”. Over time, online retailers like Amazon have realized the potential of increasing sales by offering one-off discounts to global customers. British retailers have been slower…

Read More

Egypt’s much needed lifeline

Jan Globisz The International Monetary Fund approved Egypt’s request for a $12 billion loan facility on 11th of November. Egypt has already received the first tranche of $2.75bn after having secured $6bn in additional financing. The approval came after fulfilling the three requirements set by the bank. The Egyptian pound had to be allowed to…

Read More

Outperforming in Oncology

Patricija Petkeviciute Most oncological pharmaceutical categories are comprised of markets that are at different stages of clinical maturity. For this reason, most pharma companies are still investing horizontally across a wide range of oncology categories. It is, however, vertical category leaders that are likely to be more successful as the oncology market matures. Maintaining leadership…

Read More

The interest rate is down? Should you be too?

Natalie Chaplin In August of this year, the Bank of England reduced interest rates from 0.5% to 0.25% for the first time in over 7 years. Given the time that has passed since its introduction, the ramifications of the change in monetary policy are beginning to become apparent. In the aftermath of Brexit and with…

Read More

Postponing Death

Pavit Bangur A UK court this week delivered the verdict that JS, a 14-year-old girl dying of cancer, should be allowed her wish to be cryogenically frozen. The court ruled that only her mother, who was supportive of the decision, should be able to make the decision. Her father, however, disagreed, arguing that the companies…

Read More

Bright Lights in the SolarCity

Benjamin Foster Thursday saw the confirmation of an all-stock transition of $2.6 billion merging Tesla and SolarCity after more than 85% of the voting shareholders voted in favour of the deal.  Musk sees over $150 million of cost efficiencies in the first year alone and the opportunity for Tesla to offer integrated solar roof panels…

Read More

The Future of Mobile?

Samuel Richardson Apple and Samsung have been rival antagonists since the first android smartphone hit the shelves in 2009, at each other’s throats, filing lawsuit after lawsuit in search of the perfect mobile device.  And there are those who think this fight between titans could have finally reached critical mass, with the market share of…

Read More